Richard Ding
Chief Executive Officer bij Shanghai Pinnacles Medical Technology Co., Ltd.
Profiel
Wei Ding is the founder of Shanghai Pinnacles Medical Technology Co., Ltd.
which was founded in 2020.
He held the title of Chairman & Chief Executive Officer.
Mr. Ding's former jobs include Chief Executive Officer at Biotheranostics, Inc. from 2012 to 2013, Independent Director at CombiMatrix Corp.
from 2013 to 2014, Principal at Eli Lilly & Co., Member at Myriad Genetics, Inc., and Vice President-Strategy & Business Development at bioMérieux SA from 2006 to 2008.
He was also the President of Shanghai Kehua Bio-Engineering Co., Ltd.
Mr. Ding's education includes an MBA from the University of Utah, a graduate degree from Southern Illinois University, and an undergraduate degree from Fudan University.
Actieve functies van Richard Ding
| Bedrijven | Functie | Begin |
|---|---|---|
Shanghai Pinnacles Medical Technology Co., Ltd.
 Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Chief Executive Officer | - |
Eerdere bekende functies van Richard Ding
| Bedrijven | Functie | Einde |
|---|---|---|
| COMBIMATRIX CORP | Director/Board Member | 14-09-2014 |
| BIOMÉRIEUX | Corporate Officer/Principal | 01-01-2008 |
| SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD | President | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | - |
Opleiding van Richard Ding
| University of Utah | Masters Business Admin |
| Southern Illinois University | Graduate Degree |
| Fudan University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MYRIAD GENETICS, INC. | Health Technology |
| BIOMÉRIEUX | Health Technology |
| SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
CombiMatrix Corp.
 CombiMatrix Corp. BiotechnologyHealth Technology CombiMatrix Corp. engages in the provision of clinical diagnostic services. It offers cytogenomic testing for preimplantation genetic testing, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company was founded in October 1995 and is headquartered in Irvine, CA. | Health Technology |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
Shanghai Pinnacles Medical Technology Co., Ltd.
Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Health Technology |
